ADAGIO THERAPEUTICS logo

ADAGIO THERAPEUTICS

Waltham, MA

Adagio Therapeutics is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1, and additional potentially emergent coronaviruses. They believe that antibodies will match or exceed the potency and coverage of conventional SARS-CoV-2 antibody programs and can be used as both therapeutic and durable prophylactic treatments. Their candidates are engineered using best-in-industry antibody discovery capabilities and are designed to maximize potency and duration of effect. Their portfolio includes multiple, non-competing antibodies with distinct binding targets, enabling a strategy that can avoid viral escape.

adagiotx.com

Company Details

Founded

2020

Employees

Between 50 - 200 employees

Raised

$466,000,000

Headquarters Location

Waltham, MA

Public

Yes

Acquired

No

CEO

David Hering

Founders

Laura Walker
Laura Walker
Tillman Gerngross
Tillman Gerngross

Company Collections

These are collections ADAGIO THERAPEUTICS is a part of. Click on the collection name to view similar companies.

ADAGIO THERAPEUTICS's Investors

ADAGIO THERAPEUTICS's Industries

ADAGIO THERAPEUTICS's Tech Stack

Company Collections For ADAGIO THERAPEUTICS